Clinical Trial Update: Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety of a single intravitreal injection of jCell (Famzeretcel) for Retinitis Pigmentosa; the study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• jCell (Famzeretcel) (Famzeretcel)

Snippet

Sponsor: jCyte, Inc | Conditions: Retinitis Pigmentosa | Phase 2 | Status: RECRUITING